|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/445 | (2006.01) |
| C07D 401/12 | (2006.01) | ||
| A61P 11/00 | (2006.01) |
| (11) | Number of the document | 2453894 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10732616.7 |
| Date of filing the European patent application | 2010-07-14 | |
| (97) | Date of publication of the European application | 2012-05-23 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-04 |
| (46) | Date of publication of the claims translation | 2016-02-25 |
| (86) | Number | PCT/US2010/041903 |
| Date | 2010-07-14 |
| (87) | Number | WO 2011/008809 |
| Date | 2011-01-20 |
| (30) | Number | Date | Country code |
| 225803 P | 2009-07-15 | US |
| (72) |
WOOLLAM, Grahame, GB
|
| (73) |
Theravance Biopharma R&D IP, LLC,
901 Gateway Boulevard, South San Francisco, CA 94080,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Bifenilo junginio laisvos bazės kristalinė forma |
| CRYSTALLINE FREEBASE FORM OF A BIPHENYL COMPOUND |
| Payment date | Validity (years) | Amount | |
| 2025-06-18 | 16 | 347.00 EUR |
| 2026-07-14 |